The use of animal models in diabetes research
Tóm tắt
Diabetes is a disease characterized by a relative or absolute lack of insulin, leading to hyperglycaemia. There are two main types of diabetes: type 1 diabetes and type 2 diabetes. Type 1 diabetes is due to an autoimmune destruction of the insulin‐producing pancreatic beta cells, and type 2 diabetes is caused by insulin resistance coupled by a failure of the beta cell to compensate. Animal models for type 1 diabetes range from animals with spontaneously developing autoimmune diabetes to chemical ablation of the pancreatic beta cells. Type 2 diabetes is modelled in both obese and non‐obese animal models with varying degrees of insulin resistance and beta cell failure. This review outlines some of the models currently used in diabetes research. In addition, the use of transgenic and knock‐out mouse models is discussed. Ideally, more than one animal model should be used to represent the diversity seen in human diabetic patients.
Animal Models
This paper is the latest in a series of publications on the use of animal models in pharmacology research. Readers might be interested in the previous papers.
Robinson V (2009).
Holmes AM, Rudd JA, Tattersall FD, Aziz Q, Andrews PLR (2009).
Giacomotto J and Ségalat L (2010).
McGrath JC, Drummond GB, McLachlan EM, Kilkenny C, Wainwright CL (2010).
Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG (2010).
Emerson M (2010).
Berge O‐G (2011).
Vickers SP, Jackson HC and Cheetham SC (2011).
Percie du Sert N, Holmes AM, Wallis R, Andrews PLR (2012).
The complete series including future publications, as they occur, can be found at
Từ khóa
Tài liệu tham khảo
Andrikopoulos S, 1993, Impaired regulation of hepatic fructose‐1,6‐bisphosphatase in the New Zealand obese mouse model of NIDDM, Diabetes, 42, 1731, 10.2337/diab.42.12.1731
Bonner‐Weir S, 1981, Responses of neonatal rat islets to streptozotocin: limited B‐cell regeneration and hyperglycemia, Diabetes, 30, 64, 10.2337/diab.30.1.64
Drel VR, 2011, Poly(ADP‐ribose)polymerase inhibition counteracts renal hypertrophy and multiple manifestations of peripheral neuropathy in diabetic Akita mice, Int J Mol Med, 28, 629
Girard CA, 2009, Expression of an activating mutation in the gene encoding the KATP channel subunit Kir6.2 in mouse pancreatic beta cells recapitulates neonatal diabetes, J Clin Invest, 119, 80
von Herrath MG, 1997, Pathogenesis and treatment of virus‐induced autoimmune diabetes: novel insights gained from the RIP‐LCMV transgenic mouse model, Biochem Soc Trans, 25, 630, 10.1042/bst0250630
Lavine RL, 1977, Functional abnormalities of islets of Langerhans of obese hyperglycemic mouse, Am J Physiol, 233, E86
Srinivasan K, 2007, Animal models in type 2 diabetes research: an overview, Indian J Med Res, 125, 451
Szkudelski T, 2001, The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas, Physiol Res, 50, 537